NEULAND LABORATORIES
Back to Income Statement
|
NEULAND LABORATORIES Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹260 Cr | ₹300 Cr | ₹164 Cr | ₹64 Cr | ₹81 Cr |
What is the latest Consolidated Net Profit of NEULAND LABORATORIES ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹260 Cr |
| Mar2024 | ₹300 Cr |
| Mar2023 | ₹164 Cr |
| Mar2022 | ₹64 Cr |
| Mar2021 | ₹81 Cr |
How is Consolidated Net Profit of NEULAND LABORATORIES Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹260 Cr | -13.32 | |
| Mar2024 | ₹300 Cr | 83.51 | |
| Mar2023 | ₹164 Cr | 156.21 | |
| Mar2022 | ₹64 Cr | -20.85 | |
| Mar2021 | ₹81 Cr | - | |
Compare Consolidated Net Profit of peers of NEULAND LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NEULAND LABORATORIES | ₹17,109.4 Cr | -1.8% | 4.4% | 23.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹423,195.0 Cr | 0.4% | 5.6% | 1.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹169,849.0 Cr | -0.5% | 3.3% | 7.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹149,586.0 Cr | 4.5% | 10% | 41.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹109,054.0 Cr | 1.5% | 4.8% | 9.1% | Stock Analytics | |
| CIPLA | ₹108,703.0 Cr | -1.7% | 1% | -10.5% | Stock Analytics | |
NEULAND LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NEULAND LABORATORIES | -1.8% |
4.4% |
23.8% |
| SENSEX | -1.5% |
0.8% |
8.2% |
You may also like the below Video Courses